{"ticker": {"uuid": "125f8cfb-18df-4bd2-a1a4-c526de810e9b", "symbol": "NTRA", "name": "Natera Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Insider Sell: Rowan Chapman Sells Shares of Natera Inc (NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQRjJEaWkyaTZJeGV2dE4zYWtRZjE4MGN4aHJPSUdpa245RW81NFlEWHZucnBIWkNXc3FESWFqelA0bElucURRZWg4cXRtTFZMSUMyb2d6bEZleVlGRS13azk5cU1jT1hjdmpjMVdySGRSZ05uWExsQm1lNk5qaEdhSGc0bXdrc2hoczBCNldHVGRYejlpM0tpQkZJMW9WSkhMT2NMRnBfWE9pNk9XbFE?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-18T05:03:45+00:00", "published_display": "18 Jul 2026 05:03", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera co-founder Sheena Jonathan sells $410,825 in NTRA stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQS1F5SHRKTk0tY2VWRXlSRzlYVF84U1g2Vy02VVU2aVpvT3Jyem1hZl8xZnQwWGNWa3FLTEJnWlZwQ09GN3dEY0VzTjgxWTNheVItaDNxQ01ZSXBKS1RIRVR6ZGhiM3dkazFqQVloa2lSUzZ6czZJWWpyWnhMTmJmMko2UXVOTUNjT0FBR1pTdm9tamU2ZXNhMmIzc05VMkU5Qm9id2xDR1lMTHpvd1NQRG1CZ1lkTGpaRlo2UVhJUGhjZw?oc=5", "source_name": "Investing.com", "published_at": "2026-07-18T01:58:50+00:00", "published_display": "18 Jul 2026 01:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NASDAQ: NTRA) co-founder\u2019s trusts sell 1,500 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQcWFqZU80VTNGeXZwWWxJMVF0ZEhLeU5Vb0xVaFVwQmdIaXNWM1pmOEpDUXNRR0pLQWthdjVDVHRCNGl1cHFuZ2l0NnozWWNHdk14bENHdHVZQWFSQlloaDRvXzJ2Y1FMaG1TdmthRnVmXzA1MF9EeVdxaWNvWVREaldXMC13ZkM2QjhaVktwVUd4RkVWcEdYdko2UVljZnd6bWF3eGJjYw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-18T01:17:24+00:00", "published_display": "18 Jul 2026 01:17", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NASDAQ: NTRA) director Chapman sells 135 shares in 10b5-1 trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQSjlCVDRpM1d6UGF4ZVEyTU5RUzJuTVpyTFdVcWtrelQ3NThqWnlKeUhPNWdBZ2I1WjdpUkJXQW1qZ2FEOVNpbnN2ZkVxU25GUGlFV3E5UGRmRDY2SXpJQ0xFamtYYTc5OXYxSlVRWTh5YVlSNGwtN1kwUnBLXzhXYUVINUlFVUp6Y2lJaHVPeWx4Z3FBckRUbGNpc1RoV0w1RmtfeXpCVQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-18T01:17:23+00:00", "published_display": "18 Jul 2026 01:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Finalized MolDx LCD Includes Expanded Coverage for Natera\u2019s Prospera\u2122 Portfolio", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/finalized-moldx-lcd-includes-expanded-223500172.html", "source_name": "Business Wire", "published_at": "2026-07-16T22:35:00+00:00", "published_display": "16 Jul 2026 22:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For Natera (NTRA) Could Change Following New Signatera JAMA Oncology Evidence On MRD-Guided Chemotherapy", "summary": "Natera, Inc. recently announced the resignation of Monica Bertagnolli from its Board of Directors and reported new JAMA Oncology data for its Signatera MRD test. The study, from the GALAXY arm of CIRCULATE-Japan, indicates that Signatera can identify colorectal liver metastases p", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntra/natera/news/the-bull-case-for-natera-ntra-could-change-following-new-sig/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-16T21:11:32", "published_display": "16 Jul 2026 21:11", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Natera Inc For: 15 July By Investing.com", "summary": "This article from Investing.com reports on a Form 4 filing for Natera Inc (NTRA) dated July 15. Form 4s disclose transactions by company insiders, indicating changes in their ownership of the company's stock. Natera Inc's stock is noted with a -2.72% change in the context of this", "url": "https://ng.investing.com/news/stock-market-news/form-4-natera-inc-for-15-july-93CH-2601916", "source_name": "Investing.com Nigeria", "published_at": "2026-07-16T03:09:57", "published_display": "16 Jul 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera co-founder Sheena Jonathan sells $836,898 in stock", "summary": "Natera co-founder and director Sheena Jonathan sold 3,150 shares of the company's common stock for a total of $836,898 on July 13, 2026, under a Rule 10b5-1 trading plan. The sale occurred while the stock was trading just below its 52-week high, and an InvestingPro analysis sugge", "url": "https://www.investing.com/news/insider-trading-news/natera-cofounder-sheena-jonathan-sells-836898-in-stock-93CH-4794582", "source_name": "Investing.com", "published_at": "2026-07-16T01:41:32", "published_display": "16 Jul 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) co-founder sells 3,150 shares under Rule 10b5-1 plan", "summary": "Natera, Inc. co-founder Sheena Jonathan reported the sale of 3,150 shares of common stock on July 13, 2026, under a Rule 10b5-1 trading plan adopted in December 2025. The sales occurred at weighted-average prices between $262.7160 and $268.3870 per share. Following these transact", "url": "https://www.stocktitan.net/sec-filings/NTRA/form-4-natera-inc-insider-trading-activity-37a203d8fe7b.html", "source_name": "Stock Titan", "published_at": "2026-07-16T01:41:32", "published_display": "16 Jul 2026 01:41", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NATERA INC (NTRA) Stock Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE1BRjJtNmxQYTI3VkhOaEhJODJyU1hSNDE2N2hDMTkxSE9NNENabUFUNTFjdVBxM1pLRl9UVnMwbVZwX3JvS05mWGxwLXJjZ0VoSzFSWHFTTFd1cHRaUVZCY2Vxbms?oc=5", "source_name": "ChartMill", "published_at": "2026-07-16T00:14:05+00:00", "published_display": "16 Jul 2026 00:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rowan Emma Chapman (NASDAQ: NTRA) files Form 144 to sell shares", "summary": "Rowan Emma Chapman, a security holder of Natera, Inc. (NTRA), has filed a Form 144 to sell 135 common shares with an indicated value of $37,100.70 through Morgan Stanley Smith Barney around July 15, 2026. This filing also references a previous sale of 2,964 common shares on June ", "url": "https://www.stocktitan.net/sec-filings/NTRA/144-natera-inc-sec-filing-5769615c8e8a.html", "source_name": "Stock Titan", "published_at": "2026-07-15T20:41:32", "published_display": "15 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Natera For: 15 July By Investing.com", "summary": "This article announces the filing of Form 144 for Natera (NTRA) on July 15, 2026. Form 144 indicates an intent to sell restricted securities, which can be an important piece of information for investors tracking insider transactions. The company's stock symbol NTRA is mentioned w", "url": "https://ca.investing.com/news/stock-market-news/form-144-natera-for-15-july-93CH-4735664", "source_name": "Investing.com Canada", "published_at": "2026-07-15T14:42:16", "published_display": "15 Jul 2026 14:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NTRA (NASDAQ: NTRA) holder plans sale of 1,500 common shares", "summary": "Jonathan Sheena, a holder of Natera, Inc. (NASDAQ: NTRA), has filed a Form 144 notice indicating his plan to sell 1,500 common shares. These shares, with an aggregate market value of $412,830.00, were originally acquired as founders shares on April 30, 2012, and are scheduled to ", "url": "https://www.stocktitan.net/sec-filings/NTRA/144-natera-inc-sec-filing-5f935bef5650.html", "source_name": "Stock Titan", "published_at": "2026-07-15T13:42:16", "published_display": "15 Jul 2026 13:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQSW9mM3I5d1lnaHgzVDlPNFgzSVg3MFNNVmk0N0hLcGh3dko0MF9kWUVzS1phTmdDU1NjUGFZamZZWTBmdnFfanllME9NWmhxd0JiMjJzM3JCQU9SVnY0cEx3T3JnT1pDUlh3Vy0xR1lDem9hZ2ZqdUFXd2UzU1JRbkczUEdHZ1hSRGdTN1JfSHgtLUxQVTBJRjNGbS15Z05pZVd0a25wZl9OX0VjNnp4WHVVOUxxeUVwbTJ1TmdMTzZvcEZVbTkzSDdEUFhvZTdtZC1fb3R2SFZ4ZzQ?oc=5", "source_name": "StockStory", "published_at": "2026-07-15T07:00:00+00:00", "published_display": "15 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Natera, Inc. \u2013 BX:NTRA", "summary": "This article focuses on the enterprise value to EBITDA forward of Natera, Inc. (BX:NTRA). It appears to be a financial data point from TradingView, presented without additional detailed analysis or market commentary. The content provided is primarily navigational and copyright in", "url": "https://www.tradingview.com/symbols/BX-NTRA/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-13T20:12:32", "published_display": "13 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Natera, Inc. SEC Filing", "summary": "Natera, Inc. investor Jonathan Sheena has filed a notice to sell up to 9,450 shares of common stock through Charles Schwab & Co., Inc. The shares have an aggregate market value of $2,515,779.00. The notice also details a history of multiple common stock sales by Jonathan Sheena o", "url": "https://www.stocktitan.net/sec-filings/NTRA/144-natera-inc-sec-filing-5c8815dcbf30.html", "source_name": "Stock Titan", "published_at": "2026-07-13T15:12:32", "published_display": "13 Jul 2026 15:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Natera, Inc. \u2013 XETR:45E", "summary": "This page from TradingView displays financial information for Natera, Inc. (XETR:45E), specifically focusing on its enterprise value to EBITDA forward. The content indicates that the market is closed with no recent trades and provides an overview of available financial tools and ", "url": "https://www.tradingview.com/symbols/XETR-45E/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T21:40:04", "published_display": "11 Jul 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) Stock Still Looks Expensive After A Very Large Run", "summary": "Natera (NTRA) stock has seen a significant 454.9% return over three years, yet its valuation presents a mixed picture. A Discounted Cash Flow (DCF) model suggests the stock is undervalued by 49.0% at $553 per share compared to its current price of $281.85, while market-based mult", "url": "https://finance.yahoo.com/markets/stocks/articles/natera-ntra-stock-still-looks-111519415.html", "source_name": "Market source", "published_at": "2026-07-11T07:40:04", "published_display": "11 Jul 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Did EU Class C Status for Signatera Reshape Natera\u2019s (NTRA) Long-Term Diagnostics Strategy?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/did-eu-class-c-status-051523901.html", "source_name": "Simply Wall St.", "published_at": "2026-07-11T05:15:23+00:00", "published_display": "11 Jul 2026 05:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Driving Natera's Recent Stock Action and Insider Selling", "summary": "Natera (NTRA), a genetic testing company, has shown strong growth and financial performance, fueled by its precision diagnostics in oncology. Despite significant insider selling, largely pre-planned under Rule 10b5-1, the company faces high valuation, persistent net losses, and a", "url": "https://www.kavout.com/market-lens/what-s-driving-natera-s-recent-stock-action-and-insider-selling", "source_name": "Kavout | AI", "published_at": "2026-07-11T00:09:55", "published_display": "11 Jul 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Natera (NTRA) Fully Valued As Signatera Wins EU IVDR Certification?", "summary": "Natera (NTRA) recently secured Class C certification under the EU\u2019s In Vitro Diagnostic Regulation for its Signatera cancer test, a significant regulatory achievement for long-term EU market access. The stock has seen substantial gains, with returns of 26.49% over 30 days, 46.01%", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntra/natera/news/is-natera-ntra-fully-valued-as-signatera-wins-eu-ivdr-certif", "source_name": "Simply Wall Street", "published_at": "2026-07-10T21:09:55", "published_display": "10 Jul 2026 21:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) Secures EU Certification, Is The Upside Already Priced In?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/natera-ntra-secures-eu-certification-191257124.html", "source_name": "Simply Wall St.", "published_at": "2026-07-10T19:12:57+00:00", "published_display": "10 Jul 2026 19:12", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) Signatera Data Shows Who Benefits From Chemotherapy After CRC Surgery", "summary": "New data presented in JAMA Oncology and at the ESMO GI congress highlights Natera's Signatera test for guiding adjuvant chemotherapy decisions in colorectal cancer patients, particularly those with liver metastases. The findings provide insights into which patients benefit most f", "url": "https://finance.yahoo.com/healthcare/articles/natera-ntra-signatera-data-shows-141409222.html", "source_name": "Market source", "published_at": "2026-07-10T14:14:00", "published_display": "10 Jul 2026 14:14", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NTRA's Signatera Gains EU IVDR Certification for Multiple Cancers", "summary": "Natera's molecular residual disease (MRD) test, Signatera, has received Class C certification under the EU's In Vitro Diagnostic Regulation (IVDR) for multiple cancer types, including solid tumors. This certification is a significant milestone for Natera, strengthening its positi", "url": "https://finance.yahoo.com/healthcare/articles/ntras-signatera-gains-eu-ivdr-135900002.html", "source_name": "Market source", "published_at": "2026-07-10T13:41:04", "published_display": "10 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera Receives EU IVDR Certification for Signatera", "summary": "Natera has announced that its Signatera molecular residual disease (MRD) test has received IVDR certification from the European Union. This certification allows Signatera to be marketed and sold as a CE-marked product in the EU for a broad range of solid tumor indications, demons", "url": "https://www.moomoo.com/news/post/72710531/natera-receives-eu-ivdr-certification-for-signatera", "source_name": "Moomoo", "published_at": "2026-07-10T07:40:05", "published_display": "10 Jul 2026 07:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera Announces IVDR Certification for Signatera\u2122 Across Multiple Cancers", "summary": "Natera, Inc. announced that its Signatera platform, a personalized molecular residual disease (MRD) test for solid tumors, has received Class C IVDR certification from the European Union. This certification, achieved under one of the world's most stringent regulatory frameworks, ", "url": "https://www.biospace.com/press-releases/natera-announces-ivdr-certification-for-signatera-across-multiple-cancers", "source_name": "BioSpace", "published_at": "2026-07-09T12:13:18", "published_display": "09 Jul 2026 12:13", "sentiment": "positive", "sentiment_pct": 72, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera\u2019s Signatera receives EU IVDR certification for MRD testing", "summary": "Natera Inc. announced that its Signatera test has received Class C certification under the European Union\u2019s In Vitro Diagnostic Regulation (IVDR), allowing its use for minimal residual disease testing across various cancer types. This certification, coupled with recent approvals ", "url": "https://www.investing.com/news/company-news/nateras-signatera-receives-eu-ivdr-certification-for-mrd-testing-93CH-4783398", "source_name": "Investing.com", "published_at": "2026-07-09T11:40:33", "published_display": "09 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera's Insider Selling Spree: A Red Flag Amidst Robust Growth", "summary": "Natera (NTRA) shows strong revenue growth but is experiencing significant insider selling, totaling $85.96 million in the last three months, despite analysts generally holding a bullish stance. While many sales are pre-planned 10b5-1 transactions for diversification and tax purpo", "url": "https://www.kavout.com/market-lens/natera-s-insider-selling-spree-a-red-flag-amidst-robust-growth", "source_name": "Kavout | AI", "published_at": "2026-07-09T06:40:33", "published_display": "09 Jul 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(NTRA) Volatility Zones as Tactical Triggers", "summary": "This article provides a quantitative analysis of Natera Inc. (NASDAQ: NTRA), highlighting strong sentiment across all horizons supporting an overweight bias. It outlines a lack of clear price positioning signals and notes no resistance levels above the current price, suggesting u", "url": "https://news.stocktradersdaily.com/news_release/90/NTRA_Volatility_Zones_as_Tactical_Triggers_070926021201_1783577521.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-09T02:12:00", "published_display": "09 Jul 2026 02:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) executive chair\u2019s spouse sells 1,000 shares in pre\u2011planned trade", "summary": "The spouse of Natera, Inc. executive chairman Matthew Rabinowitz sold 1,000 shares of common stock at $280 per share on July 6, 2026, as part of a pre-arranged Rule 10b5-1 trading plan. This transaction, totaling $280,000, represents a small portion of Rabinowitz's overall indire", "url": "https://www.stocktitan.net/sec-filings/NTRA/form-4-natera-inc-insider-trading-activity-abab5d1e03d6.html", "source_name": "Stock Titan", "published_at": "2026-07-09T02:09:51", "published_display": "09 Jul 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera chief legal officer Daniel Rabinowitz sells $4.57m stock", "summary": "Daniel Rabinowitz, Natera Inc.'s Chief Legal Officer, sold 16,800 shares of company stock for approximately $4.57 million on July 1, 2026. This sale was conducted under a Rule 10b5-1 trading plan adopted in December 2025, leaving him with 172,294 shares. The transaction occurred ", "url": "https://www.investing.com/news/insider-trading-news/natera-chief-legal-officer-daniel-rabinowitz-sells-457m-stock-93CH-4778154", "source_name": "Investing.com", "published_at": "2026-07-07T04:13:47", "published_display": "07 Jul 2026 04:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Natera Inc For: 6 July By Investing.com", "summary": "This article from Investing.com reports on a Form 4 filing for Natera Inc. (NTRA) related to July 6th. The content primarily consists of financial market data, indices, commodity prices, and other news headlines from Investing.com, with the specific details of the Form 4 not expl", "url": "https://ng.investing.com/news/stock-market-news/form-4-natera-inc-for-6-july-93CH-2588014", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T02:14:00", "published_display": "07 Jul 2026 02:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) legal chief sells 16,800 shares under Rule 10b5-1 plan", "summary": "Daniel Rabinowitz, the Secretary and Chief Legal Officer of Natera, Inc. (NTRA), sold 16,800 shares of common stock through 12 separate open-market transactions on July 1, 2026. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on December 5, 2025. ", "url": "https://www.stocktitan.net/sec-filings/NTRA/form-4-natera-inc-insider-trading-activity-c940158bc006.html", "source_name": "Stock Titan", "published_at": "2026-07-07T02:10:40", "published_display": "07 Jul 2026 02:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) president sells 3,000 shares under Rule 10b5-1 trading plan", "summary": "Solomon Moshkevich, President of Clinical Diagnostics at Natera (NTRA), reported selling 3,000 shares of common stock on July 1, 2026. These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted in November 2024. The shares were sold in open-market transaction", "url": "https://www.stocktitan.net/sec-filings/NTRA/form-4-natera-inc-insider-trading-activity-7ae1fb330202.html", "source_name": "Stock Titan", "published_at": "2026-07-07T02:10:40", "published_display": "07 Jul 2026 02:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera chief legal officer Daniel Rabinowitz sells $4.57m stock By Investing.com", "summary": "Natera's Chief Legal Officer, Daniel Rabinowitz, sold 16,800 shares of company stock totaling approximately $4.57 million on July 1, 2026, through a pre-arranged trading plan. This sale occurred while Natera's stock is near its 52-week high and is considered overvalued according ", "url": "https://au.investing.com/news/stock-market-news/natera-chief-legal-officer-daniel-rabinowitz-sells-457m-stock-93CH-4520096", "source_name": "Investing.com Australia", "published_at": "2026-07-07T01:10:40", "published_display": "07 Jul 2026 01:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Board member Monica Bertagnolli exits Natera (NASDAQ: NTRA)", "summary": "Monica Bertagnolli has resigned from Natera's Board of Directors and all associated committees, effective July 1, 2026. Her departure is attributed to a new position at the National Academy of Medicine and is not due to any disagreements with the company's operations, policies, o", "url": "https://www.stocktitan.net/sec-filings/NTRA/8-k-natera-inc-reports-material-event-be9090cff49e.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:10:40", "published_display": "06 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $300", "summary": "Evercore has reiterated its Buy rating on Natera (NTRA.US) and increased its price target for the company to $300. This adjustment reflects continued confidence in Natera's financial prospects and market position.", "url": "https://www.moomoo.com/news/post/72526707/evercore-maintains-natera-ntraus-with-buy-rating-raises-target-price", "source_name": "Moomoo", "published_at": "2026-07-06T19:13:18", "published_display": "06 Jul 2026 19:13", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera Inc focuses on genetic testing growth as investors watch Nasdaq trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNVXBvdXJ3d1dEQnJ0XzgzWENxT1B2bTZDWTlFX1NlVFg0TUdaZHdwMFVQeEEyd3Jmek9TUHdxTUZZTHNVQTJSbmhyUnRMVzhzUThjdGxfYVJSZVBSb0lKV2JzM2EzNWJSbDFEOGVReXlwVWxxbUxVdDduMTFOMTBxenlsRmdDUmNpUGZNTE03MlJOWWRTaWpsVkdUQi1fM2pFaUlQV0xlVTlEa0xXTjlnZlZpVUpNazZTZjZSR21CdHBNdVlsYUs2eA?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) Stock Jumps 10.7%: Will It Continue to Soar?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPSUxHMGd0THVwT3N5WU1XbG4yOVp3X29lZ3JjNlBrMWdrUWkxYjNnUHpCMEtIV1hYcjZOaEgwMmJMVTVUSlkzT1R0ZkE5U1pmcERieGRkbWdnSFFseEFiYzBmZVdqM2RZTktZc1BtczVQb1RUbU9ORUhETU9fVGJZQkJ3Nk15VDZ2NXVuc0xWSTBrdm9MV2c?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Natera (NTRA) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOUDd2RFZsd0E0OVFnYUduQl85c2FncElTdFN5ZWkwNVRFR0RlV3laVm0zRFphc0pGZ0x5Y3BZVjdUVng2eWlzRDZfeEZrRnRNVDRPUmlXRjAwZnlYdURheUlnOUNzeEtyd2VEWUFQeVg0TzdHUkdqWEQ3d1h6aGFtSDQ0c2tfX0s2bjNaLXNxdDJHdlRmbnNR?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) Stock Fair Value Edges Lower As MRD And Signatera Debate Splits Analysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNUFZYelhnMERIeUZCMkY1UHFrVXQ2Y21XaWR3cmdJSDRTS2Q0eVMtUWE2ZGJ5UDNBRkk3VUJSb1AzRmRiS0xDTllIeEtQZndXYWM1ZjBvenl4R21uUHpqaDJGM0pMQXZaSmJJd3FHclphUlQ1b0hUZGR6QXRHRjA5MlJmSllpZ1JKMDZoMTRFdFhkdzJ2YnR4aQ?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs Initiates Coverage on Natera, Inc. (NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNSzc0RXlSdThoRm9zdUE3QWNOUmQ0MnNjYUp5VExzeWZEWFlwSFppOTJJN3BkMG80WjA4MWpucHp2cHBkcVlsc1BxQ2FYVldjaVFzclNybUVlVE5JVnA5dG81Ny05OTFKQk81MGVtWkF3RkNCYVpYai0wY1FndHotOG9NU1Y4UEtEeHZYWDBKNXdDTzNHR0RjOVVndjhoU2gxWjB6OElGWQ?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Have Natera Insiders Been Selling Stock?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs initiates Natera stock with Neutral rating, $245 target", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQM1JpMExUVHdHWEJDTmJveTFqTWsxU3pMSkxjMlg1bTdFWmRhSGJIN2oteVI4YlRHS05mTHlpeUMwWWxQcVI4VGhvTEFPaTFDZHVaYnN3cTBDLU4wamV0bFh2amF4cGhzOTd3bkhtS2hIb3QtcVM4YmtzankzVU5Cbks3RnNUR1JjQVFKcjZ4R1hIOVdnMlBrdFlUMmFnd1JOVXo0R1pVdWktcy0wYWNOX1IydnQzejZXVG1zMWItVHU4QlpXRkE?oc=5", "source_name": "Investing.com", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Keytruda developer and cancer center chief join Natera board", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNSmI4MHdEcy00WTdxMjJHdEQ2Xy1pbHBfbGZzTGFPc0t3OVBybHRLc3NtaTlRZ3RKZDQ0V1VwUW1ydEl0LUVZdDQtbGZpemZaZ1ZfUmtHRnZJQVJlM2hFWmZaeDExcHhKX2U2bFc1R1Z1OFNGQnZPSGFFd0JWbFNkajdNVnRPWTZ5R1I2dlJtU3JKZzVlb3JBMThEdEYyMFpIUVh4cVBZd09pVlQ1Y3JyMlVNcW5HWExTUE1uM2NzVQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera And 2 Other Companies That May Be Trading Below Their Estimated Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNVVFnUTdNMWkyOEZFZnpYWlFBWWxhM1BRcE52SU1kNFd0NjRvcmdLQVZxLWtya0E5SmNjNFVEQm44MUYtcjdpR2VLUkJXY044ZU53WENtQnhaUFVmR3B1anhkUkpoVXpLUnFTajgyNTlRM2ZMbmV1T2tGZzlTNGFFZXE3dThhVGp0Vmx4M01QaE9DUTQtVV9NOA?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Natera (NTRA) Investment Story Is Shifting With New Guidance And Analyst Revisions", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZUZkbGstRW9kck9QM0lJSjFIbmZqY19BTFpHRlZvUzRuS19JelFBeS1kWVFNQ296bllFZ2RVN0V6LVhXNFloZWhwclNUYnd5czVReUdzNVVxMXYyYXZBdlRiR3pnT1F5d3FxNThtWUVjc0tHdlkwc0hHX1Z6b0N0S3FRcHduaGxaR0ZlVTktRE54UTZ0bFdGUU9ULW5KY1pSbTdvWg?oc=5", "source_name": "Market source", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reconsider Natera (NTRA) After Its Strong Five Year Share Price Gain", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Made A Financial Statement On Natera, Inc.'s (NASDAQ:NTRA) First-Quarter Report", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) Q4 Profit Of US$47.3 Million Tests Longstanding Loss\u2011Making Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera co-founder Sheena Jonathan sells $22,059 in common stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNa3VfMGkzWjU4QkJuZHI5VXJOVWFvaFl3TmN2TGoyYmNlSWVzMm12cDY1QmhIa2FHaHBDZDNEMG1QNlFZcHVZc2JJVUV6TVR3VDNPS3I4bzlzeThQRF9teDVMU29yTDQ2QmVFendOckw1TVFnc3p6VkN0Umxxclg5ZmdFc1d1ajZOTXZvVVpzSEF3QWNMaW1oZjFWZC1tbUpVWHVrNHR5QnowMGdpY1B4NUdGMWR3b2ozeU1QblpFX0U2M28?oc=5", "source_name": "Investing.com", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vanguard Capital Management holds 7.21M Natera shares (NTRA) in Schedule 13G", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNb25xRUNLaVdTMW12SndHUk02aUVJNFYxbDdsV2p6NDgtd0V3RDhoQVE5dkdVamV2bFVpUGR3RHhUdWQ2d3c3QkhtSVFvVjRHUHRXZ05CVnIxSS02ZlFzTWdqSlh5WnJlZVhRcW83MzI2TG40ZnQ5QmhFVldUSUc5Qm14NlNsX0R0eXpRSDh5am9hNEVkSWZMRzhDOGZLcXVzbUZmX0ZxTDBsVFZrVkQ3WHRGV3NPR2ZT?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "William Blair initiates Natera stock with Outperform on growth outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQN2FTNjNGNjhHUkp3cGVORUxqak40b29DZE5oR0FHNTE2cUJIZmE2YXB0RzVHVXZSS0RhWE04dmRDblItZHAwcW8ybDFmS2h2OExoUzhmZTBtUS1YVTlTSHVLRGo4UjBwR0NzbEVIbC1scXA4c2RQR0JhVzJOaGhKdlJMMTdXcElGWE91T0pCTjI5YjdDS21EM2JoQlg2ZHdNQVdVWHlMMGNlczZsYTNoUGRrMTRlR1lVSWREYmpmUXZJUHBrRWJxcjlB?oc=5", "source_name": "Investing.com", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Driving Natera's Recent Stock Action", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQdUptOV9abnB2R3daZE82Sm16ZnBLY3I2bWo1Nk9ZZ3M0U2FJYUQyNFFnM09UQzBSaWQ4c0tnSnp1S01Wa00tYnhfbGNoc1BtcXh2MWhYY09zZG5zSkJsSWFaaTZZSnJ4UC1YLWgzRTlqaXh5MU5vOG9ybUpWTG14eS11Z2Q?oc=5", "source_name": "Kavout | AI", "published_at": "2026-03-17T04:42:02+00:00", "published_display": "17 Mar 2026 04:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Natera genome test targets faster answers for rare disease families", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQRVVMVVlMQ1lYQjV3SzJndnptRE9WanQ2Vmc1WGowUVJCYTlLU0U2U1RJcTgxUDUzRUdtSHBkZW1KVmlZR1l1eUI5M1drMkw0Y3laVVgwTWZCdGxUMEYwZG1aaW9GTG9za2ZyVVp5amZkNWptalJWclpGZml4TWpKQ2Y4b3V1RnVvNjdBZk5ING9VQ0N6QTUtRnZLN2R0VTExcnVrVVliUnlWb2ljbDlyb3NPZTVoR2ZESnlTZg?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeneDx stock falls as Natera launches competing rare disease test", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOQk81TVR0RUtpUktqaVFtc2syTWx5aXZmZlBvRjFUeks1clh5dlI3dGJHdDFYVTVnNGx6MDlhQUhXUXpDd0NEOHJqbUxpQUc3enBLZ0hoSEFqLV9aeGdwSUVHenJDaFN6NGlfRU91MTdSVDEtWkVpa0FlMDJLN0Z5cm8wOVhJMHJ5dkpqVWt6N295VHVnZmc5Y29VbnVvWW0yWEtTdUFQX2lUMUppRTJTWGNfaGZrbkxGN3hRUUdjNHVkT29Kd1E?oc=5", "source_name": "Investing.com", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Insider Sell: Rowan Chapman Sells Shares of Natera Inc (NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQRjJEaWkyaTZJeGV2dE4zYWtRZjE4MGN4aHJPSUdpa245RW81NFlEWHZucnBIWkNXc3FESWFqelA0bElucURRZWg4cXRtTFZMSUMyb2d6bEZleVlGRS13azk5cU1jT1hjdmpjMVdySGRSZ05uWExsQm1lNk5qaEdhSGc0bXdrc2hoczBCNldHVGRYejlpM0tpQkZJMW9WSkhMT2NMRnBfWE9pNk9XbFE?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-18T05:03:45+00:00", "published_display": "18 Jul 2026 05:03", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera co-founder Sheena Jonathan sells $410,825 in NTRA stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQS1F5SHRKTk0tY2VWRXlSRzlYVF84U1g2Vy02VVU2aVpvT3Jyem1hZl8xZnQwWGNWa3FLTEJnWlZwQ09GN3dEY0VzTjgxWTNheVItaDNxQ01ZSXBKS1RIRVR6ZGhiM3dkazFqQVloa2lSUzZ6czZJWWpyWnhMTmJmMko2UXVOTUNjT0FBR1pTdm9tamU2ZXNhMmIzc05VMkU5Qm9id2xDR1lMTHpvd1NQRG1CZ1lkTGpaRlo2UVhJUGhjZw?oc=5", "source_name": "Investing.com", "published_at": "2026-07-18T01:58:50+00:00", "published_display": "18 Jul 2026 01:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NASDAQ: NTRA) co-founder\u2019s trusts sell 1,500 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQcWFqZU80VTNGeXZwWWxJMVF0ZEhLeU5Vb0xVaFVwQmdIaXNWM1pmOEpDUXNRR0pLQWthdjVDVHRCNGl1cHFuZ2l0NnozWWNHdk14bENHdHVZQWFSQlloaDRvXzJ2Y1FMaG1TdmthRnVmXzA1MF9EeVdxaWNvWVREaldXMC13ZkM2QjhaVktwVUd4RkVWcEdYdko2UVljZnd6bWF3eGJjYw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-18T01:17:24+00:00", "published_display": "18 Jul 2026 01:17", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NASDAQ: NTRA) director Chapman sells 135 shares in 10b5-1 trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQSjlCVDRpM1d6UGF4ZVEyTU5RUzJuTVpyTFdVcWtrelQ3NThqWnlKeUhPNWdBZ2I1WjdpUkJXQW1qZ2FEOVNpbnN2ZkVxU25GUGlFV3E5UGRmRDY2SXpJQ0xFamtYYTc5OXYxSlVRWTh5YVlSNGwtN1kwUnBLXzhXYUVINUlFVUp6Y2lJaHVPeWx4Z3FBckRUbGNpc1RoV0w1RmtfeXpCVQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-18T01:17:23+00:00", "published_display": "18 Jul 2026 01:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Finalized MolDx LCD Includes Expanded Coverage for Natera\u2019s Prospera\u2122 Portfolio", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/finalized-moldx-lcd-includes-expanded-223500172.html", "source_name": "Business Wire", "published_at": "2026-07-16T22:35:00+00:00", "published_display": "16 Jul 2026 22:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For Natera (NTRA) Could Change Following New Signatera JAMA Oncology Evidence On MRD-Guided Chemotherapy", "summary": "Natera, Inc. recently announced the resignation of Monica Bertagnolli from its Board of Directors and reported new JAMA Oncology data for its Signatera MRD test. The study, from the GALAXY arm of CIRCULATE-Japan, indicates that Signatera can identify colorectal liver metastases p", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntra/natera/news/the-bull-case-for-natera-ntra-could-change-following-new-sig/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-16T21:11:32", "published_display": "16 Jul 2026 21:11", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Natera Inc For: 15 July By Investing.com", "summary": "This article from Investing.com reports on a Form 4 filing for Natera Inc (NTRA) dated July 15. Form 4s disclose transactions by company insiders, indicating changes in their ownership of the company's stock. Natera Inc's stock is noted with a -2.72% change in the context of this", "url": "https://ng.investing.com/news/stock-market-news/form-4-natera-inc-for-15-july-93CH-2601916", "source_name": "Investing.com Nigeria", "published_at": "2026-07-16T03:09:57", "published_display": "16 Jul 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera co-founder Sheena Jonathan sells $836,898 in stock", "summary": "Natera co-founder and director Sheena Jonathan sold 3,150 shares of the company's common stock for a total of $836,898 on July 13, 2026, under a Rule 10b5-1 trading plan. The sale occurred while the stock was trading just below its 52-week high, and an InvestingPro analysis sugge", "url": "https://www.investing.com/news/insider-trading-news/natera-cofounder-sheena-jonathan-sells-836898-in-stock-93CH-4794582", "source_name": "Investing.com", "published_at": "2026-07-16T01:41:32", "published_display": "16 Jul 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) co-founder sells 3,150 shares under Rule 10b5-1 plan", "summary": "Natera, Inc. co-founder Sheena Jonathan reported the sale of 3,150 shares of common stock on July 13, 2026, under a Rule 10b5-1 trading plan adopted in December 2025. The sales occurred at weighted-average prices between $262.7160 and $268.3870 per share. Following these transact", "url": "https://www.stocktitan.net/sec-filings/NTRA/form-4-natera-inc-insider-trading-activity-37a203d8fe7b.html", "source_name": "Stock Titan", "published_at": "2026-07-16T01:41:32", "published_display": "16 Jul 2026 01:41", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NATERA INC (NTRA) Stock Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE1BRjJtNmxQYTI3VkhOaEhJODJyU1hSNDE2N2hDMTkxSE9NNENabUFUNTFjdVBxM1pLRl9UVnMwbVZwX3JvS05mWGxwLXJjZ0VoSzFSWHFTTFd1cHRaUVZCY2Vxbms?oc=5", "source_name": "ChartMill", "published_at": "2026-07-16T00:14:05+00:00", "published_display": "16 Jul 2026 00:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rowan Emma Chapman (NASDAQ: NTRA) files Form 144 to sell shares", "summary": "Rowan Emma Chapman, a security holder of Natera, Inc. (NTRA), has filed a Form 144 to sell 135 common shares with an indicated value of $37,100.70 through Morgan Stanley Smith Barney around July 15, 2026. This filing also references a previous sale of 2,964 common shares on June ", "url": "https://www.stocktitan.net/sec-filings/NTRA/144-natera-inc-sec-filing-5769615c8e8a.html", "source_name": "Stock Titan", "published_at": "2026-07-15T20:41:32", "published_display": "15 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Natera For: 15 July By Investing.com", "summary": "This article announces the filing of Form 144 for Natera (NTRA) on July 15, 2026. Form 144 indicates an intent to sell restricted securities, which can be an important piece of information for investors tracking insider transactions. The company's stock symbol NTRA is mentioned w", "url": "https://ca.investing.com/news/stock-market-news/form-144-natera-for-15-july-93CH-4735664", "source_name": "Investing.com Canada", "published_at": "2026-07-15T14:42:16", "published_display": "15 Jul 2026 14:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NTRA (NASDAQ: NTRA) holder plans sale of 1,500 common shares", "summary": "Jonathan Sheena, a holder of Natera, Inc. (NASDAQ: NTRA), has filed a Form 144 notice indicating his plan to sell 1,500 common shares. These shares, with an aggregate market value of $412,830.00, were originally acquired as founders shares on April 30, 2012, and are scheduled to ", "url": "https://www.stocktitan.net/sec-filings/NTRA/144-natera-inc-sec-filing-5f935bef5650.html", "source_name": "Stock Titan", "published_at": "2026-07-15T13:42:16", "published_display": "15 Jul 2026 13:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQSW9mM3I5d1lnaHgzVDlPNFgzSVg3MFNNVmk0N0hLcGh3dko0MF9kWUVzS1phTmdDU1NjUGFZamZZWTBmdnFfanllME9NWmhxd0JiMjJzM3JCQU9SVnY0cEx3T3JnT1pDUlh3Vy0xR1lDem9hZ2ZqdUFXd2UzU1JRbkczUEdHZ1hSRGdTN1JfSHgtLUxQVTBJRjNGbS15Z05pZVd0a25wZl9OX0VjNnp4WHVVOUxxeUVwbTJ1TmdMTzZvcEZVbTkzSDdEUFhvZTdtZC1fb3R2SFZ4ZzQ?oc=5", "source_name": "StockStory", "published_at": "2026-07-15T07:00:00+00:00", "published_display": "15 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Natera, Inc. \u2013 BX:NTRA", "summary": "This article focuses on the enterprise value to EBITDA forward of Natera, Inc. (BX:NTRA). It appears to be a financial data point from TradingView, presented without additional detailed analysis or market commentary. The content provided is primarily navigational and copyright in", "url": "https://www.tradingview.com/symbols/BX-NTRA/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-13T20:12:32", "published_display": "13 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Natera, Inc. SEC Filing", "summary": "Natera, Inc. investor Jonathan Sheena has filed a notice to sell up to 9,450 shares of common stock through Charles Schwab & Co., Inc. The shares have an aggregate market value of $2,515,779.00. The notice also details a history of multiple common stock sales by Jonathan Sheena o", "url": "https://www.stocktitan.net/sec-filings/NTRA/144-natera-inc-sec-filing-5c8815dcbf30.html", "source_name": "Stock Titan", "published_at": "2026-07-13T15:12:32", "published_display": "13 Jul 2026 15:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Natera, Inc. \u2013 XETR:45E", "summary": "This page from TradingView displays financial information for Natera, Inc. (XETR:45E), specifically focusing on its enterprise value to EBITDA forward. The content indicates that the market is closed with no recent trades and provides an overview of available financial tools and ", "url": "https://www.tradingview.com/symbols/XETR-45E/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T21:40:04", "published_display": "11 Jul 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) Stock Still Looks Expensive After A Very Large Run", "summary": "Natera (NTRA) stock has seen a significant 454.9% return over three years, yet its valuation presents a mixed picture. A Discounted Cash Flow (DCF) model suggests the stock is undervalued by 49.0% at $553 per share compared to its current price of $281.85, while market-based mult", "url": "https://finance.yahoo.com/markets/stocks/articles/natera-ntra-stock-still-looks-111519415.html", "source_name": "Market source", "published_at": "2026-07-11T07:40:04", "published_display": "11 Jul 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Did EU Class C Status for Signatera Reshape Natera\u2019s (NTRA) Long-Term Diagnostics Strategy?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/did-eu-class-c-status-051523901.html", "source_name": "Simply Wall St.", "published_at": "2026-07-11T05:15:23+00:00", "published_display": "11 Jul 2026 05:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Driving Natera's Recent Stock Action and Insider Selling", "summary": "Natera (NTRA), a genetic testing company, has shown strong growth and financial performance, fueled by its precision diagnostics in oncology. Despite significant insider selling, largely pre-planned under Rule 10b5-1, the company faces high valuation, persistent net losses, and a", "url": "https://www.kavout.com/market-lens/what-s-driving-natera-s-recent-stock-action-and-insider-selling", "source_name": "Kavout | AI", "published_at": "2026-07-11T00:09:55", "published_display": "11 Jul 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Natera (NTRA) Fully Valued As Signatera Wins EU IVDR Certification?", "summary": "Natera (NTRA) recently secured Class C certification under the EU\u2019s In Vitro Diagnostic Regulation for its Signatera cancer test, a significant regulatory achievement for long-term EU market access. The stock has seen substantial gains, with returns of 26.49% over 30 days, 46.01%", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntra/natera/news/is-natera-ntra-fully-valued-as-signatera-wins-eu-ivdr-certif", "source_name": "Simply Wall Street", "published_at": "2026-07-10T21:09:55", "published_display": "10 Jul 2026 21:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) Secures EU Certification, Is The Upside Already Priced In?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/natera-ntra-secures-eu-certification-191257124.html", "source_name": "Simply Wall St.", "published_at": "2026-07-10T19:12:57+00:00", "published_display": "10 Jul 2026 19:12", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) Signatera Data Shows Who Benefits From Chemotherapy After CRC Surgery", "summary": "New data presented in JAMA Oncology and at the ESMO GI congress highlights Natera's Signatera test for guiding adjuvant chemotherapy decisions in colorectal cancer patients, particularly those with liver metastases. The findings provide insights into which patients benefit most f", "url": "https://finance.yahoo.com/healthcare/articles/natera-ntra-signatera-data-shows-141409222.html", "source_name": "Market source", "published_at": "2026-07-10T14:14:00", "published_display": "10 Jul 2026 14:14", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NTRA's Signatera Gains EU IVDR Certification for Multiple Cancers", "summary": "Natera's molecular residual disease (MRD) test, Signatera, has received Class C certification under the EU's In Vitro Diagnostic Regulation (IVDR) for multiple cancer types, including solid tumors. This certification is a significant milestone for Natera, strengthening its positi", "url": "https://finance.yahoo.com/healthcare/articles/ntras-signatera-gains-eu-ivdr-135900002.html", "source_name": "Market source", "published_at": "2026-07-10T13:41:04", "published_display": "10 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera Receives EU IVDR Certification for Signatera", "summary": "Natera has announced that its Signatera molecular residual disease (MRD) test has received IVDR certification from the European Union. This certification allows Signatera to be marketed and sold as a CE-marked product in the EU for a broad range of solid tumor indications, demons", "url": "https://www.moomoo.com/news/post/72710531/natera-receives-eu-ivdr-certification-for-signatera", "source_name": "Moomoo", "published_at": "2026-07-10T07:40:05", "published_display": "10 Jul 2026 07:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera Announces IVDR Certification for Signatera\u2122 Across Multiple Cancers", "summary": "Natera, Inc. announced that its Signatera platform, a personalized molecular residual disease (MRD) test for solid tumors, has received Class C IVDR certification from the European Union. This certification, achieved under one of the world's most stringent regulatory frameworks, ", "url": "https://www.biospace.com/press-releases/natera-announces-ivdr-certification-for-signatera-across-multiple-cancers", "source_name": "BioSpace", "published_at": "2026-07-09T12:13:18", "published_display": "09 Jul 2026 12:13", "sentiment": "positive", "sentiment_pct": 72, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera\u2019s Signatera receives EU IVDR certification for MRD testing", "summary": "Natera Inc. announced that its Signatera test has received Class C certification under the European Union\u2019s In Vitro Diagnostic Regulation (IVDR), allowing its use for minimal residual disease testing across various cancer types. This certification, coupled with recent approvals ", "url": "https://www.investing.com/news/company-news/nateras-signatera-receives-eu-ivdr-certification-for-mrd-testing-93CH-4783398", "source_name": "Investing.com", "published_at": "2026-07-09T11:40:33", "published_display": "09 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera's Insider Selling Spree: A Red Flag Amidst Robust Growth", "summary": "Natera (NTRA) shows strong revenue growth but is experiencing significant insider selling, totaling $85.96 million in the last three months, despite analysts generally holding a bullish stance. While many sales are pre-planned 10b5-1 transactions for diversification and tax purpo", "url": "https://www.kavout.com/market-lens/natera-s-insider-selling-spree-a-red-flag-amidst-robust-growth", "source_name": "Kavout | AI", "published_at": "2026-07-09T06:40:33", "published_display": "09 Jul 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(NTRA) Volatility Zones as Tactical Triggers", "summary": "This article provides a quantitative analysis of Natera Inc. (NASDAQ: NTRA), highlighting strong sentiment across all horizons supporting an overweight bias. It outlines a lack of clear price positioning signals and notes no resistance levels above the current price, suggesting u", "url": "https://news.stocktradersdaily.com/news_release/90/NTRA_Volatility_Zones_as_Tactical_Triggers_070926021201_1783577521.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-09T02:12:00", "published_display": "09 Jul 2026 02:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) executive chair\u2019s spouse sells 1,000 shares in pre\u2011planned trade", "summary": "The spouse of Natera, Inc. executive chairman Matthew Rabinowitz sold 1,000 shares of common stock at $280 per share on July 6, 2026, as part of a pre-arranged Rule 10b5-1 trading plan. This transaction, totaling $280,000, represents a small portion of Rabinowitz's overall indire", "url": "https://www.stocktitan.net/sec-filings/NTRA/form-4-natera-inc-insider-trading-activity-abab5d1e03d6.html", "source_name": "Stock Titan", "published_at": "2026-07-09T02:09:51", "published_display": "09 Jul 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera chief legal officer Daniel Rabinowitz sells $4.57m stock", "summary": "Daniel Rabinowitz, Natera Inc.'s Chief Legal Officer, sold 16,800 shares of company stock for approximately $4.57 million on July 1, 2026. This sale was conducted under a Rule 10b5-1 trading plan adopted in December 2025, leaving him with 172,294 shares. The transaction occurred ", "url": "https://www.investing.com/news/insider-trading-news/natera-chief-legal-officer-daniel-rabinowitz-sells-457m-stock-93CH-4778154", "source_name": "Investing.com", "published_at": "2026-07-07T04:13:47", "published_display": "07 Jul 2026 04:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Natera Inc For: 6 July By Investing.com", "summary": "This article from Investing.com reports on a Form 4 filing for Natera Inc. (NTRA) related to July 6th. The content primarily consists of financial market data, indices, commodity prices, and other news headlines from Investing.com, with the specific details of the Form 4 not expl", "url": "https://ng.investing.com/news/stock-market-news/form-4-natera-inc-for-6-july-93CH-2588014", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T02:14:00", "published_display": "07 Jul 2026 02:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) legal chief sells 16,800 shares under Rule 10b5-1 plan", "summary": "Daniel Rabinowitz, the Secretary and Chief Legal Officer of Natera, Inc. (NTRA), sold 16,800 shares of common stock through 12 separate open-market transactions on July 1, 2026. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on December 5, 2025. ", "url": "https://www.stocktitan.net/sec-filings/NTRA/form-4-natera-inc-insider-trading-activity-c940158bc006.html", "source_name": "Stock Titan", "published_at": "2026-07-07T02:10:40", "published_display": "07 Jul 2026 02:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) president sells 3,000 shares under Rule 10b5-1 trading plan", "summary": "Solomon Moshkevich, President of Clinical Diagnostics at Natera (NTRA), reported selling 3,000 shares of common stock on July 1, 2026. These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted in November 2024. The shares were sold in open-market transaction", "url": "https://www.stocktitan.net/sec-filings/NTRA/form-4-natera-inc-insider-trading-activity-7ae1fb330202.html", "source_name": "Stock Titan", "published_at": "2026-07-07T02:10:40", "published_display": "07 Jul 2026 02:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera chief legal officer Daniel Rabinowitz sells $4.57m stock By Investing.com", "summary": "Natera's Chief Legal Officer, Daniel Rabinowitz, sold 16,800 shares of company stock totaling approximately $4.57 million on July 1, 2026, through a pre-arranged trading plan. This sale occurred while Natera's stock is near its 52-week high and is considered overvalued according ", "url": "https://au.investing.com/news/stock-market-news/natera-chief-legal-officer-daniel-rabinowitz-sells-457m-stock-93CH-4520096", "source_name": "Investing.com Australia", "published_at": "2026-07-07T01:10:40", "published_display": "07 Jul 2026 01:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Board member Monica Bertagnolli exits Natera (NASDAQ: NTRA)", "summary": "Monica Bertagnolli has resigned from Natera's Board of Directors and all associated committees, effective July 1, 2026. Her departure is attributed to a new position at the National Academy of Medicine and is not due to any disagreements with the company's operations, policies, o", "url": "https://www.stocktitan.net/sec-filings/NTRA/8-k-natera-inc-reports-material-event-be9090cff49e.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:10:40", "published_display": "06 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $300", "summary": "Evercore has reiterated its Buy rating on Natera (NTRA.US) and increased its price target for the company to $300. This adjustment reflects continued confidence in Natera's financial prospects and market position.", "url": "https://www.moomoo.com/news/post/72526707/evercore-maintains-natera-ntraus-with-buy-rating-raises-target-price", "source_name": "Moomoo", "published_at": "2026-07-06T19:13:18", "published_display": "06 Jul 2026 19:13", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera Inc focuses on genetic testing growth as investors watch Nasdaq trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNVXBvdXJ3d1dEQnJ0XzgzWENxT1B2bTZDWTlFX1NlVFg0TUdaZHdwMFVQeEEyd3Jmek9TUHdxTUZZTHNVQTJSbmhyUnRMVzhzUThjdGxfYVJSZVBSb0lKV2JzM2EzNWJSbDFEOGVReXlwVWxxbUxVdDduMTFOMTBxenlsRmdDUmNpUGZNTE03MlJOWWRTaWpsVkdUQi1fM2pFaUlQV0xlVTlEa0xXTjlnZlZpVUpNazZTZjZSR21CdHBNdVlsYUs2eA?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) Stock Jumps 10.7%: Will It Continue to Soar?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPSUxHMGd0THVwT3N5WU1XbG4yOVp3X29lZ3JjNlBrMWdrUWkxYjNnUHpCMEtIV1hYcjZOaEgwMmJMVTVUSlkzT1R0ZkE5U1pmcERieGRkbWdnSFFseEFiYzBmZVdqM2RZTktZc1BtczVQb1RUbU9ORUhETU9fVGJZQkJ3Nk15VDZ2NXVuc0xWSTBrdm9MV2c?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Natera (NTRA) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOUDd2RFZsd0E0OVFnYUduQl85c2FncElTdFN5ZWkwNVRFR0RlV3laVm0zRFphc0pGZ0x5Y3BZVjdUVng2eWlzRDZfeEZrRnRNVDRPUmlXRjAwZnlYdURheUlnOUNzeEtyd2VEWUFQeVg0TzdHUkdqWEQ3d1h6aGFtSDQ0c2tfX0s2bjNaLXNxdDJHdlRmbnNR?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) Stock Fair Value Edges Lower As MRD And Signatera Debate Splits Analysts", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNUFZYelhnMERIeUZCMkY1UHFrVXQ2Y21XaWR3cmdJSDRTS2Q0eVMtUWE2ZGJ5UDNBRkk3VUJSb1AzRmRiS0xDTllIeEtQZndXYWM1ZjBvenl4R21uUHpqaDJGM0pMQXZaSmJJd3FHclphUlQ1b0hUZGR6QXRHRjA5MlJmSllpZ1JKMDZoMTRFdFhkdzJ2YnR4aQ?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs Initiates Coverage on Natera, Inc. (NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNSzc0RXlSdThoRm9zdUE3QWNOUmQ0MnNjYUp5VExzeWZEWFlwSFppOTJJN3BkMG80WjA4MWpucHp2cHBkcVlsc1BxQ2FYVldjaVFzclNybUVlVE5JVnA5dG81Ny05OTFKQk81MGVtWkF3RkNCYVpYai0wY1FndHotOG9NU1Y4UEtEeHZYWDBKNXdDTzNHR0RjOVVndjhoU2gxWjB6OElGWQ?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Have Natera Insiders Been Selling Stock?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs initiates Natera stock with Neutral rating, $245 target", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQM1JpMExUVHdHWEJDTmJveTFqTWsxU3pMSkxjMlg1bTdFWmRhSGJIN2oteVI4YlRHS05mTHlpeUMwWWxQcVI4VGhvTEFPaTFDZHVaYnN3cTBDLU4wamV0bFh2amF4cGhzOTd3bkhtS2hIb3QtcVM4YmtzankzVU5Cbks3RnNUR1JjQVFKcjZ4R1hIOVdnMlBrdFlUMmFnd1JOVXo0R1pVdWktcy0wYWNOX1IydnQzejZXVG1zMWItVHU4QlpXRkE?oc=5", "source_name": "Investing.com", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Keytruda developer and cancer center chief join Natera board", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNSmI4MHdEcy00WTdxMjJHdEQ2Xy1pbHBfbGZzTGFPc0t3OVBybHRLc3NtaTlRZ3RKZDQ0V1VwUW1ydEl0LUVZdDQtbGZpemZaZ1ZfUmtHRnZJQVJlM2hFWmZaeDExcHhKX2U2bFc1R1Z1OFNGQnZPSGFFd0JWbFNkajdNVnRPWTZ5R1I2dlJtU3JKZzVlb3JBMThEdEYyMFpIUVh4cVBZd09pVlQ1Y3JyMlVNcW5HWExTUE1uM2NzVQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera And 2 Other Companies That May Be Trading Below Their Estimated Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNVVFnUTdNMWkyOEZFZnpYWlFBWWxhM1BRcE52SU1kNFd0NjRvcmdLQVZxLWtya0E5SmNjNFVEQm44MUYtcjdpR2VLUkJXY044ZU53WENtQnhaUFVmR3B1anhkUkpoVXpLUnFTajgyNTlRM2ZMbmV1T2tGZzlTNGFFZXE3dThhVGp0Vmx4M01QaE9DUTQtVV9NOA?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Natera (NTRA) Investment Story Is Shifting With New Guidance And Analyst Revisions", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZUZkbGstRW9kck9QM0lJSjFIbmZqY19BTFpHRlZvUzRuS19JelFBeS1kWVFNQ296bllFZ2RVN0V6LVhXNFloZWhwclNUYnd5czVReUdzNVVxMXYyYXZBdlRiR3pnT1F5d3FxNThtWUVjc0tHdlkwc0hHX1Z6b0N0S3FRcHduaGxaR0ZlVTktRE54UTZ0bFdGUU9ULW5KY1pSbTdvWg?oc=5", "source_name": "Market source", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reconsider Natera (NTRA) After Its Strong Five Year Share Price Gain", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Made A Financial Statement On Natera, Inc.'s (NASDAQ:NTRA) First-Quarter Report", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera (NTRA) Q4 Profit Of US$47.3 Million Tests Longstanding Loss\u2011Making Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Natera co-founder Sheena Jonathan sells $22,059 in common stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNa3VfMGkzWjU4QkJuZHI5VXJOVWFvaFl3TmN2TGoyYmNlSWVzMm12cDY1QmhIa2FHaHBDZDNEMG1QNlFZcHVZc2JJVUV6TVR3VDNPS3I4bzlzeThQRF9teDVMU29yTDQ2QmVFendOckw1TVFnc3p6VkN0Umxxclg5ZmdFc1d1ajZOTXZvVVpzSEF3QWNMaW1oZjFWZC1tbUpVWHVrNHR5QnowMGdpY1B4NUdGMWR3b2ozeU1QblpFX0U2M28?oc=5", "source_name": "Investing.com", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vanguard Capital Management holds 7.21M Natera shares (NTRA) in Schedule 13G", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNb25xRUNLaVdTMW12SndHUk02aUVJNFYxbDdsV2p6NDgtd0V3RDhoQVE5dkdVamV2bFVpUGR3RHhUdWQ2d3c3QkhtSVFvVjRHUHRXZ05CVnIxSS02ZlFzTWdqSlh5WnJlZVhRcW83MzI2TG40ZnQ5QmhFVldUSUc5Qm14NlNsX0R0eXpRSDh5am9hNEVkSWZMRzhDOGZLcXVzbUZmX0ZxTDBsVFZrVkQ3WHRGV3NPR2ZT?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "William Blair initiates Natera stock with Outperform on growth outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQN2FTNjNGNjhHUkp3cGVORUxqak40b29DZE5oR0FHNTE2cUJIZmE2YXB0RzVHVXZSS0RhWE04dmRDblItZHAwcW8ybDFmS2h2OExoUzhmZTBtUS1YVTlTSHVLRGo4UjBwR0NzbEVIbC1scXA4c2RQR0JhVzJOaGhKdlJMMTdXcElGWE91T0pCTjI5YjdDS21EM2JoQlg2ZHdNQVdVWHlMMGNlczZsYTNoUGRrMTRlR1lVSWREYmpmUXZJUHBrRWJxcjlB?oc=5", "source_name": "Investing.com", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Driving Natera's Recent Stock Action", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQdUptOV9abnB2R3daZE82Sm16ZnBLY3I2bWo1Nk9ZZ3M0U2FJYUQyNFFnM09UQzBSaWQ4c0tnSnp1S01Wa00tYnhfbGNoc1BtcXh2MWhYY09zZG5zSkJsSWFaaTZZSnJ4UC1YLWgzRTlqaXh5MU5vOG9ybUpWTG14eS11Z2Q?oc=5", "source_name": "Kavout | AI", "published_at": "2026-03-17T04:42:02+00:00", "published_display": "17 Mar 2026 04:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Natera genome test targets faster answers for rare disease families", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQRVVMVVlMQ1lYQjV3SzJndnptRE9WanQ2Vmc1WGowUVJCYTlLU0U2U1RJcTgxUDUzRUdtSHBkZW1KVmlZR1l1eUI5M1drMkw0Y3laVVgwTWZCdGxUMEYwZG1aaW9GTG9za2ZyVVp5amZkNWptalJWclpGZml4TWpKQ2Y4b3V1RnVvNjdBZk5ING9VQ0N6QTUtRnZLN2R0VTExcnVrVVliUnlWb2ljbDlyb3NPZTVoR2ZESnlTZg?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeneDx stock falls as Natera launches competing rare disease test", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOQk81TVR0RUtpUktqaVFtc2syTWx5aXZmZlBvRjFUeks1clh5dlI3dGJHdDFYVTVnNGx6MDlhQUhXUXpDd0NEOHJqbUxpQUc3enBLZ0hoSEFqLV9aeGdwSUVHenJDaFN6NGlfRU91MTdSVDEtWkVpa0FlMDJLN0Z5cm8wOVhJMHJ5dkpqVWt6N295VHVnZmc5Y29VbnVvWW0yWEtTdUFQX2lUMUppRTJTWGNfaGZrbkxGN3hRUUdjNHVkT29Kd1E?oc=5", "source_name": "Investing.com", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 107, "total_relevant": 56, "sentiment_summary": {"positive": 12, "negative": 8, "neutral": 36, "score": 52, "total": 56, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 88, "events": [{"event": "general", "label": "Market update", "weight": 24.75, "count": 45}, {"event": "earnings", "label": "Earnings", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 12, "negative_events": 8}, "market_context": {"has_market_context": true, "latest_close": 269.95, "latest_week": "2026-07-10", "one_week_move": -3.4, "four_week_move": 27.3, "twelve_week_move": 29.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.304241, "market_dynamics_buy_signal": false, "relative_strength": 14.951826, "fair_value_gap": 92.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 57.3251, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.4% over one week, +27.3% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 13}, {"label": "Market source", "count": 9}, {"label": "Investing.com", "count": 8}, {"label": "simplywall.st", "count": 4}, {"label": "Kavout | AI", "count": 3}, {"label": "Simply Wall Street", "count": 2}, {"label": "Investing.com Nigeria", "count": 2}, {"label": "TradingView", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 56}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 45}, {"label": "Earnings", "count": 3}, {"label": "Regulatory and legal", "count": 2}, {"label": "Analyst action", "count": 2}, {"label": "Guidance", "count": 2}, {"label": "Balance sheet", "count": 1}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "88/100 classification confidence."}, {"label": "Company focus", "value": "56", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-3.4% over one week, +27.3% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Insider Sell: Rowan Chapman Sells Shares of Natera Inc (NTRA)"}], "updated_at": "2026-07-18T07:35:05.899582+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}